Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kaveri Pohlman Profile - BTIG Analyst
18 Followers
Kaveri Pohlman BTIG
Wall Street Analyst
Success Rate
26 out of 115 ratings made a profit
Average Return
-26.20%
Average return per rating
Time Frame
Compare to
Copying Kaveri Pohlman's trades since 2022 and holding each position for 1 Year would result in 22.61% of your transactions generating a profit, with an average return of -26.2% per rating.
Stock Rating Distribution
84.09% Buy
15.91% Hold
0.00% Sell
Distribution of Kaveri Pohlman's ratings
Additional Information
Main Sector:General
Geo Coverage:
US Market
US MarketBest Rating
Stock:
Checkmate Pharmaceuticals, Inc.
(CMPI)
(CMPI)
Rating:Buy
Date:Apr 11, 2022 - Apr 19, 2022
Return:+269.60%
The most profitable rating made by Kaveri Pohlman
Kaveri Pohlman's Stock Coverage
Checkmate Pharmaceuticals
Apr 19, 2022
Hold
Downgraded
―
4Ratings
+214.80%
CytomX Therapeutics
Jul 06, 2022
Buy
Assigned
$8.00
(444.22% Upside)
3Ratings
-56.13%
OncoSec Medical
Nov 23, 2022
Hold
Downgraded
―
6Ratings
-80.58%
Oncternal Therapeutics
May 05, 2023
Hold
Assigned
―
4Ratings
-68.17%
Sonnet BioTherapeutics Holdings
Aug 14, 2023
Buy
Assigned
$2.00
(28.21% Upside)
6Ratings
-81.85%
NexImmune
Sep 01, 2023
Hold
Assigned
―
3Ratings
-83.60%
G1 Therapeutics
Oct 13, 2023
Hold
Assigned
―
11Ratings
-51.55%
Seagen
Nov 01, 2023
Hold
Assigned
―
12Ratings
―
0.00%
Nuvation Bio
Nov 02, 2023
Hold
Reiterated
―
8Ratings
-65.27%
MacroGenics
Nov 06, 2023
Buy
Assigned
$12.00
(37.77% Upside)
11Ratings
+3.62%
List of latest recommendations made by Kaveri Pohlman. Click to expand and see Kaveri Pohlman's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >Kaveri Pohlman activity FAQ
What is the performance of Kaveri Pohlman's recommendations?
The percentage of profitable recommendations made by Kaveri Pohlman is 23%, and the average return per transaction is -26.20%.
What was Kaveri Pohlman’s latest rating?
Kaveri Pohlman latest rating was a buy on AMAM with a price target of $26.00, which represents an Upside of 94.90%
What was Kaveri Pohlman's most profitable rating?
Kaveri Pohlman’s most profitable ratings was a buy on CMPI stock on Apr 11, 2022 - Apr 19, 2022. The return on the trade was +269.60%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here